MedTrace Logo

Real-world Insights of People With Human Immunodeficiency Virus (HIV) Infection

NCT03400293 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1184

Last updated 2019-03-11

No results posted yet for this study

Summary

This study is designed to identify the burden associated with HIV and its treatment, and assess their health-related quality of life (HRQoL) by measuring key HRQoL domains, including satisfaction with treatment and care, and internalised stigma (ISAT). The study will also explore data for various important subpopulations such as subjects who are virally suppressed; who we anticipate will be the majority of study subjects. The study design is an observational, cross sectional study employing subjects' own mobile phone devices for data entry.

Conditions

  • HIV Infections

Interventions

OTHER

Functional Assessment of HIV Infection

Functional Assessment of HIV Infection will be used to assess HRQoL of subjects. This will include 47 items.

OTHER

Patient Satisfaction Questionnaire

Patient Satisfaction Questionnaire will be used to assess burden and HRQoL in subjects. This will include 18 items.

OTHER

Symptom Distress Module

Symptom Distress Module will be used to assess burden and HRQoL in subjects. This will include 20 items.

OTHER

Patient Health Questionnaire

Patient Health Questionnaire will be used to assess burden and HRQoL in subjects. This will include 2 items.

OTHER

Internalized Stigma of AIDS Tool

Internalized Stigma of AIDS Tool will be used to assess burden and HRQoL in subjects. This will include 10 items.

OTHER

Medication adherence visual analogue scale

Medication adherence visual analogue scale will be used to assess burden and HRQoL in subjects. This will include 1 item.

Sponsors & Collaborators

  • Evidera

    collaborator INDUSTRY

  • mProve

    collaborator UNKNOWN

  • ViiV Healthcare

    lead INDUSTRY

Principal Investigators

  • GSK Clinical Trials · ViiV Healthcare

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-18
Primary Completion
2018-07-07
Completion
2018-07-07

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03400293 on ClinicalTrials.gov